Skip to contentG
GRI Bio, Inc.
G
GRIGRI Bio, Inc. Released Nov 13, 2026, after the close
10-Q filed Nov 13, 2026, 44 days after period end · 0001824293-26-000070
Q3 2026 · 10-Q
Revenue—
Net Income-$1.51M-$1.51MN/M vs Q3 2025N/M vs Q2 2026 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GRI Bio, Inc. · CIK 1824293 · Engraved from SEC EDGAR
-$0.69-$0.69N/M vs Q3 2025N/M vs Q2 2026 Operating Income-$1,511,000N/M Operating Cash Flowderived-$1,475,000N/M Filing lag
ended Sep 30, 2026 · filed Nov 13, 2026 · 44 d after period end